Friday, May 15, 2015
Karen Estelle Woodin, Ph.D., known in the clinical trials industry as a long-time industry consultant and author, passed away last week after a short bout with malignant endometrial cancer. She was 74.
Korea National Enterprise for Clinical Trials (KoNECT) and DIA (Drug Information Association), based in Washington, D.C., have signed a Memorandum of Understanding (MoU) to establish a cooperative relationship and explore collaboration in development of training, education and knowledge exchange opportunities.
The Center for Information and Study on Clinical Research Participation (CISCRP), an independent nonprofit, is launching an annual 5K run and walk event in San Diego this June to celebrate the volunteers who give the gift of participation in clinical research.
DIA, a neutral, global, professional member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related healthcare products, has named Barbara Lopez Kunz global chief executive, to lead the organization beginning in September. Kunz brings worldwide leadership experience to DIA as former president of the global health and life sciences business at Battelle, an international science and technology nonprofit organization that explores emerging areas of science, develops and commercializes technology and manages laboratories.
BBK is empowering attendees of DIA’s 49th annual meeting, in Boston June 23-27, to support victims of the Boston Marathon attacks. In the spirit of using “mobile for good”—and leveraging BBK’s mobile platform—meeting attendees can text “Boston Strong” to 617-706-4000 any time during the conference.
Icon,a global provider of outsourced development, has formed a collaboration with DIA, a neutral, global, professional, member-driven association of nearly 18,000 pharmaceutical, biotechnology, and medical device professionals, to deliver the first solution-provider webinar, which offers free access to knowledge and innovative solutions to overcome some of the key challenges in medical product development.
DIA, a neutral, global, professional and member-driven association of nearly 18,000 professionals, announced the arrival of Stephen P. Spielberg, M.D., Ph.D., as editor-in-chief of the newly launched, official DIA peer-reviewed scientific journal, Therapeutic Innovation & Regulatory Science (TIRS).